← Open Payments lookup

KOTI REYNOLDS: Open Payments

NPI 1285333674 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,738 in 175 payments from 49 companies in 2025. Trend: 2023 $2,247 · 2024 $3,209 · 2025 $4,738

Food & beverage: $3,741Long term medical supply or device loan: $997
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation25$1,316
Janssen Biotech, Inc.18$375
Merck Sharp & Dohme LLC9$215
ABBVIE INC.8$208
AstraZeneca Pharmaceuticals LP10$205
Gilead Sciences, Inc.8$194
Incyte Corporation8$187
SOBI, INC6$155
Astellas Pharma US Inc6$144
Takeda Pharmaceuticals U.S.A., Inc.4$130

Products named: KISQALI, KEYTRUDA, RYBREVANT, Trodelvy, JAKAFI, Vyloy, ENHERTU, Vonjo.

Industry payments across TX — which companies pay providers there.